Evelo Biosciences
Balkrishan (Simba) Gill, Ph.D. has served as our President, Chief Executive Officer and member of our board of directors since September 2015. Dr. Gill has also served on the board of directors of Realm Therapeutics PLC since 2016, and as a Venture Partner at Flagship Pioneering, a life sciences innovation enterprise, since 2015. From 2006 to 2015, Dr. Gill served as the President and Chief Executive Officer of moksha8 Pharmaceuticals, Inc., a pharmaceutical company. Dr. Gill received his Ph.D. from King’s College, London and his M.B.A. from INSEAD.
This person is not in any offices
Evelo Biosciences
1 followers
Evelo Biosciences is a clinical-stage biotechnology company developing orally delivered product candidates that are designed to act on the small intestinal axis, SINTAX™, with systemic therapeutic effects.